JPY 788.0
(-0.63%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 11.3 Billion JPY | 34.49% |
2022 | 8.4 Billion JPY | -5.58% |
2021 | 8.9 Billion JPY | 41.1% |
2020 | 6.31 Billion JPY | -27.75% |
2019 | 8.73 Billion JPY | 21.28% |
2018 | 7.2 Billion JPY | -33.34% |
2017 | 10.8 Billion JPY | 14.9% |
2016 | 9.4 Billion JPY | -9.61% |
2015 | 10.4 Billion JPY | -0.73% |
2014 | 10.48 Billion JPY | 15.9% |
2013 | 9.04 Billion JPY | -1.26% |
2012 | 9.15 Billion JPY | -14.56% |
2011 | 10.71 Billion JPY | 62.94% |
2010 | 6.57 Billion JPY | -9.99% |
2009 | 7.3 Billion JPY | 23.74% |
2008 | 5.9 Billion JPY | -15.3% |
2007 | 6.97 Billion JPY | 8.77% |
2006 | 6.41 Billion JPY | -3.43% |
2005 | 6.63 Billion JPY | 29.72% |
2004 | 5.11 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 8.68 Billion JPY | -23.21% |
2023 Q3 | 8.16 Billion JPY | 1.09% |
2023 FY | 11.3 Billion JPY | 34.49% |
2023 Q1 | 7.51 Billion JPY | -10.67% |
2023 Q4 | 11.3 Billion JPY | 38.51% |
2023 Q2 | 8.07 Billion JPY | 7.52% |
2022 Q3 | 6.87 Billion JPY | -14.88% |
2022 Q2 | 8.07 Billion JPY | 5.13% |
2022 Q1 | 7.67 Billion JPY | -13.8% |
2022 FY | 8.4 Billion JPY | -5.58% |
2022 Q4 | 8.4 Billion JPY | 22.4% |
2021 Q4 | 8.9 Billion JPY | 5.86% |
2021 FY | 8.9 Billion JPY | 41.1% |
2021 Q1 | 7.85 Billion JPY | 24.46% |
2021 Q2 | 7.9 Billion JPY | 0.62% |
2021 Q3 | 8.41 Billion JPY | 6.43% |
2020 Q1 | 7.24 Billion JPY | -17.03% |
2020 Q2 | 6.49 Billion JPY | -10.33% |
2020 Q4 | 6.31 Billion JPY | -1.34% |
2020 Q3 | 6.39 Billion JPY | -1.55% |
2020 FY | 6.31 Billion JPY | -27.75% |
2019 Q4 | 8.73 Billion JPY | 14.53% |
2019 Q1 | 6.4 Billion JPY | -11.15% |
2019 Q2 | 6.79 Billion JPY | 6.14% |
2019 FY | 8.73 Billion JPY | 21.28% |
2019 Q3 | 7.62 Billion JPY | 12.29% |
2018 Q1 | 7.83 Billion JPY | -27.47% |
2018 Q3 | 6.25 Billion JPY | -9.73% |
2018 FY | 7.2 Billion JPY | -33.34% |
2018 Q2 | 6.92 Billion JPY | -11.59% |
2018 Q4 | 7.2 Billion JPY | 15.16% |
2017 Q4 | 10.8 Billion JPY | -4.13% |
2017 Q2 | 10.67 Billion JPY | 16.31% |
2017 Q1 | 9.17 Billion JPY | -2.44% |
2017 FY | 10.8 Billion JPY | 14.9% |
2017 Q3 | 11.27 Billion JPY | 5.62% |
2016 FY | 9.4 Billion JPY | -9.61% |
2016 Q2 | 9.34 Billion JPY | -2.99% |
2016 Q1 | 9.63 Billion JPY | -7.41% |
2016 Q4 | 9.4 Billion JPY | -4.51% |
2016 Q3 | 9.84 Billion JPY | 5.38% |
2015 Q1 | 10.84 Billion JPY | 3.46% |
2015 Q3 | 11.36 Billion JPY | -0.07% |
2015 Q4 | 10.4 Billion JPY | -8.43% |
2015 Q2 | 11.37 Billion JPY | 4.86% |
2015 FY | 10.4 Billion JPY | -0.73% |
2014 FY | 10.48 Billion JPY | 15.9% |
2014 Q2 | 8.5 Billion JPY | 1.41% |
2014 Q4 | 10.48 Billion JPY | 19.95% |
2014 Q3 | 8.73 Billion JPY | 2.73% |
2014 Q1 | 8.38 Billion JPY | -7.24% |
2013 Q4 | 9.04 Billion JPY | -0.66% |
2013 FY | 9.04 Billion JPY | -1.26% |
2013 Q3 | 9.1 Billion JPY | 1.63% |
2013 Q2 | 8.95 Billion JPY | 2.19% |
2013 Q1 | 8.76 Billion JPY | -4.29% |
2012 Q2 | 8.78 Billion JPY | 2.75% |
2012 Q3 | 9.21 Billion JPY | 4.93% |
2012 Q4 | 9.15 Billion JPY | -0.67% |
2012 FY | 9.15 Billion JPY | -14.56% |
2012 Q1 | 8.55 Billion JPY | -20.22% |
2011 FY | 10.71 Billion JPY | 62.94% |
2011 Q1 | 6.84 Billion JPY | 4.04% |
2011 Q2 | 7.16 Billion JPY | 4.68% |
2011 Q3 | 7.97 Billion JPY | 11.32% |
2011 Q4 | 10.71 Billion JPY | 34.39% |
2010 Q1 | 6.77 Billion JPY | -7.35% |
2010 Q3 | 7.08 Billion JPY | 7.88% |
2010 Q4 | 6.57 Billion JPY | -7.1% |
2010 FY | 6.57 Billion JPY | -9.99% |
2010 Q2 | 6.56 Billion JPY | -3.06% |
2009 Q3 | 6.64 Billion JPY | 4.74% |
2009 FY | 7.3 Billion JPY | 23.74% |
2009 Q4 | 7.3 Billion JPY | 9.91% |
2009 Q2 | 6.34 Billion JPY | 0.0% |
2008 Q3 | 4.79 Billion JPY | 0.0% |
2008 Q4 | 5.9 Billion JPY | 23.25% |
2008 FY | 5.9 Billion JPY | -15.3% |
2007 FY | 6.97 Billion JPY | 8.77% |
2006 FY | 6.41 Billion JPY | -3.43% |
2005 FY | 6.63 Billion JPY | 29.72% |
2004 FY | 5.11 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
DVx Inc. | 13.48 Billion JPY | 16.107% |
Eiken Chemical Co., Ltd. | 15.67 Billion JPY | 27.872% |
Create Medic Co., Ltd. | 4.31 Billion JPY | -162.122% |
PHC Holdings Corporation | 425.15 Billion JPY | 97.34% |
Techno Medica Co., Ltd. | 3.61 Billion JPY | -212.811% |
Rion Co., Ltd. | 8.2 Billion JPY | -37.876% |
Nihon Kohden Corporation | 52.14 Billion JPY | 78.314% |
Fukuda Denshi Co., Ltd. | 42.46 Billion JPY | 73.371% |
Japan Lifeline Co., Ltd. | 15.58 Billion JPY | 27.413% |
Japan Medical Dynamic Marketing, INC. | 5.88 Billion JPY | -92.263% |
3-D Matrix, Ltd. | 5.53 Billion JPY | -104.393% |
CYBERDYNE Inc. | 9.52 Billion JPY | -18.755% |